Casanova Acebes Lab
@casanova_acebes
Group Leader @CNIOStopCancer. Myeloid cells&immunotherapy @academiajoven @ContraCancerEs @criscancer @FundacionFero #RyC @ERC_Research
ID: 851188869118734338
https://casanovaacebeslab.com/ 09-04-2017 21:43:35
3,3K Tweet
3,3K Followers
1,1K Following
It's one thing to have a cell atlas of the human body. It's another to build foundation #AI models, test perturbations, and establish causal effects. An insightful review/perspective Cell cell.com/cell/fulltext/… Jenny Rood, Ph.D. Anna Hupalowska Aviv Regev Genentech
Excited to share our new paper showing shear stress triggers neutrophil extracellular traps formation, central to inflammation and clot formation. Grateful to my amazing team and collaborators! Habiba Danish Baker Institute RMIT Research Nature Communications rdcu.be/dRJk9
Don’t forget to register to this fantastic free workshop on 7th October at Centro de Biología Molecular Severo Ochoa. We will discuss the last findings regarding Genome Organization, Chromatin remodeling, Epigenetic modifications and Genome instability in Cancer. Last available slots. More details here👇🏻
🗣#CFM_immunomodulation Closing Lecture will be held by Karin de Visser from The Netherlands Cancer Institute Oncode Institute. "Dissecting how breast tumors hijack myelopoiesis to promote metastasis". 📅 October 16-18th at #CNIOStopCancer 🤝Supported by CaixaResearch. 🔗Info: cnio.es/eventos/fronti…
📢 ¡Últimas plazas para realizar el "Máster de Bioinformática y Ciencia de Datos en Medicina Personalizada de Precisión y Salud" del Instituto de Salud Carlos III (ISCIII) ! ¡¡No pierdas la oportunidad!! 📌Empezamos el 30 Sept! ℹ️masterbioinformatica.com BSC-CNS CNIO Stop Cancer InstitutoRoche SSebiot
Very exciting opportunity to work on harnessing computational approaches to develop T cell immunotherapies for childhood cancers. please RT! Karin Straathof💙🎗 Cancer Grand Challenges #nexTGen #childhoodcancer #Immunotherapy #cancerevolution
Ni que lo digas Marina García Macia . Gracias por las que mueven el cambio Dr. María D. Mayán et al.
What is the impact of immune checkpoint inhibitors in the outcome of patients with early breast cancer? Check out this huge work led by Guillermo Villacampa and Tomás Pascual Treatment tailoring is paramount to improve patient care! ESMO - Eur. Oncology OncoAlert Vall d’Hebron Institute of Oncology (VHIO) ASCO
Conference planning for the new course starts! And I have no bias to 💯 recommend the next #CFM_immunomodulation at CNIO Stop Cancer honored to welcome an amazing line-up of speakers. Come and join us!
Thrilled to be speaking Society for Immunotherapy of Cancer 2024 I-O Drug Development Summit in Boston from 9/30-10/1. Talks from Ignacio Melero, Priti Hegde from Kite, a Gilead Company, Jedd Wolchok, and others. Hope to see you in Boston! sitcancer.org/education/drug…
Congrats José Javier Fuster & team💪🏽
I'm excited to share that, in just a week, I'll be presenting our work on hematopoietic aging and cancer from the lab of Miriam Merad, MD, PhD Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute at #CICON24 Cancer Research Institute. Looking forward to seeing everyone there!
This incredible paper by Petter Brodin is what the field has been waiting for! It's shocking the extent to which testosterone regulates the components of the immune system which are dysregulated in the infection-associated chronic illnesses! Type I IFN responses ⬇️ NK function ⬆️
Thrilled to share our first study on aging from Miriam Merad, MD, PhD lab Icahn School of Medicine at Mount Sinai The Tisch Cancer Institute Lipschultz Precision Immunology Institute in which we demonstrate how aging promotes cancer. We show that: (1/n) science.org/doi/10.1126/sc…